Compare NAD & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAD | ATRC |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | N/A | 2005 |
| Metric | NAD | ATRC |
|---|---|---|
| Price | $10.37 | $57.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $55.78 |
| AVG Volume (30 Days) | ★ 2.2M | 869.9K |
| Earning Date | 01-01-0001 | 11-03-2026 |
| Dividend Yield | ★ 4.35% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $13.42 |
| Revenue Next Year | N/A | $12.12 |
| P/E Ratio | ★ N/A | $320.69 |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $9.66 | $25.36 |
| 52 Week High | $12.31 | $61.70 |
| Indicator | NAD | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 57.13 |
| Support Level | $9.75 | $26.95 |
| Resistance Level | $11.92 | $61.70 |
| Average True Range (ATR) | 0.19 | 2.13 |
| MACD | 0.08 | -0.15 |
| Stochastic Oscillator | 82.17 | 77.20 |
Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.